- Home
- OSUR vs TSAT Comparison
OSUR vs TSAT Comparison
Compare OSUR & TSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSUR
- TSAT
- Stock Information
- Founded
- OSUR 2000
- TSAT 1969
- Country
- OSUR United States
- TSAT Canada
- Employees
- OSUR N/A
- TSAT N/A
- Industry
- OSUR Medical/Dental Instruments
- TSAT Metal Fabrications
- Sector
- OSUR Health Care
- TSAT Industrials
- Exchange
- OSUR Nasdaq
- TSAT Nasdaq
- Market Cap
- OSUR 266.7M
- TSAT N/A
- IPO Year
- OSUR 1986
- TSAT 1996
- Fundamental
- Price
- OSUR $3.44
- TSAT $20.89
- Analyst Decision
- OSUR Hold
- TSAT Hold
- Analyst Count
- OSUR 2
- TSAT 1
- Target Price
- OSUR $5.50
- TSAT $9.00
- AVG Volume (30 Days)
- OSUR 1.0M
- TSAT 103.5K
- Earning Date
- OSUR 05-07-2025
- TSAT 05-09-2025
- Dividend Yield
- OSUR N/A
- TSAT N/A
- EPS Growth
- OSUR N/A
- TSAT N/A
- EPS
- OSUR N/A
- TSAT 2.55
- Revenue
- OSUR $185,827,000.00
- TSAT $450,756,875.00
- Revenue This Year
- OSUR N/A
- TSAT N/A
- Revenue Next Year
- OSUR $8.41
- TSAT N/A
- P/E Ratio
- OSUR N/A
- TSAT $9.01
- Revenue Growth
- OSUR N/A
- TSAT N/A
- 52 Week Low
- OSUR $2.69
- TSAT $6.93
- 52 Week High
- OSUR $6.69
- TSAT $25.38
- Technical
- Relative Strength Index (RSI)
- OSUR 45.82
- TSAT 52.65
- Support Level
- OSUR $3.40
- TSAT $20.60
- Resistance Level
- OSUR $3.55
- TSAT $25.38
- Average True Range (ATR)
- OSUR 0.15
- TSAT 2.12
- MACD
- OSUR 0.02
- TSAT 0.19
- Stochastic Oscillator
- OSUR 56.52
- TSAT 54.09
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.